Fractyl Health (GUTS) Convertible Debt (2023 - 2025)
Fractyl Health (GUTS) reported Convertible Debt of $20.9 million for Q4 2025, little changed year-on-year from $20.9 million in Q4 2024, and little changed quarter-over-quarter from $20.9 million in Q3 2025.
Fractyl Health (GUTS) has 3 years of Convertible Debt data on file, last reported at $20.9 million in Q4 2025.
- For the quarter ending Q4 2025, Convertible Debt changed 0.0% year-over-year to $20.9 million; the trailing twelve-month figure through Dec 2025 stood at $20.9 million (changed 0.0% YoY), and the FY2025 full-year result was $20.9 million, changed 0.0% from the prior year.
- Convertible Debt for Q4 2025 stood at $20.9 million, roughly flat from $20.9 million in the prior quarter.
- Across five years, Convertible Debt topped out at $27.2 million in Q4 2023 and bottomed at $20.9 million in Q1 2024.
- A 3-year average of $21.6 million and a median of $20.9 million in 2025 frame the typical range for Convertible Debt.
- Across the five-year window, Convertible Debt fell 23.06% in 2024 and gained 0.0% in 2025, its largest moves.
- Tracing GUTS's Convertible Debt over 3 years: stood at $27.2 million in 2023, then fell by 23.06% to $20.9 million in 2024, then increased by 0.0% to $20.9 million in 2025.
- According to Business Quant data, Convertible Debt over the past three periods registered $20.9 million, $20.9 million, and $20.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.90 Mn |
| Sep 30, 2025 | 20.90 Mn |
| Jun 30, 2025 | 20.90 Mn |
| Mar 31, 2025 | 20.90 Mn |
| Dec 31, 2024 | 20.90 Mn |
| Sep 30, 2024 | 20.90 Mn |
| Jun 30, 2024 | 20.90 Mn |
| Mar 31, 2024 | 20.90 Mn |
| Dec 31, 2023 | 27.16 Mn |